Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model.
Decaup E, Jean C, Laurent C, Gravelle P, Fruchon S, Capilla F, Marrot A, Al Saati T, Frenois FX, Laurent G, Klein C, Varoqueaux N, Savina A, Fournié JJ, Bezombes C.
Decaup E, et al. Among authors: gravelle p.
Blood Cancer J. 2013 Aug 9;3(8):e131. doi: 10.1038/bcj.2013.32.
Blood Cancer J. 2013.
PMID: 23933705
Free PMC article.